Genetic counseling for congenital heart disease - Practice resource of the National Society of Genetic Counselors.

complex disease congenital heart disease genetic counseling genetic testing practice resource

Journal

Journal of genetic counseling
ISSN: 1573-3599
Titre abrégé: J Genet Couns
Pays: United States
ID NLM: 9206865

Informations de publication

Date de publication:
02 2022
Historique:
revised: 02 08 2021
received: 09 01 2021
accepted: 02 08 2021
pubmed: 13 9 2021
medline: 8 3 2022
entrez: 12 9 2021
Statut: ppublish

Résumé

Congenital heart disease (CHD) is an indication which spans multiple specialties across various genetic counseling practices. This practice resource aims to provide guidance on key considerations when approaching counseling for this particular indication while recognizing the rapidly changing landscape of knowledge within this domain. This resource was developed with consensus from a diverse group of certified genetic counselors utilizing literature relevant for CHD genetic counseling practice and is aimed at supporting genetic counselors who encounter this indication in their practice both pre- and postnatally.

Identifiants

pubmed: 34510635
doi: 10.1002/jgc4.1498
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

9-33

Informations de copyright

© 2021 National Society of Genetic Counselors.

Références

Ahrens-Nicklas, R. C., Khan, S., Garbarini, J., Woyciechowski, S., D'Alessandro, L., Zackai, E. H., Deardorff, M. A., & Goldmuntz, E. (2016). Utility of genetic evaluation in infants with congenital heart defects admitted to the cardiac intensive care unit. American Journal of Medical Genetics Part A, 170(12), 3090-3097. https://doi.org/10.1002/ajmg.a.37891
Almesned, S., Al-Akhfash, A., & Mesned, A. A. (2013). Social impact on families of children with complex congenital heart disease. Annals of Saudi Medicine, 33(2), 140-143. https://doi.org/10.5144/0256-4947.2013.140
Anderson, K., Cnota, J., James, J., Miller, E. M., Parrott, A., Pilipenko, V., Weaver, K. N., & Shikany, A. (2019). Prevalence of Noonan spectrum disorders in a pediatric population with valvar pulmonary stenosis. Congenital Heart Disease, 14(2), 264-273. https://doi.org/10.1111/chd.12721
Baumgartner, H., De Backer, J., Babu-Narayan, S. V., Budts, W., Chessa, M., Diller, G.-P., lung, B., Kluin, J., Lang, I. M., Meijboom, F., Moons, P., Mulder, B. J. M., Oechslin, E., Roos-Hesselink, J. W., Schwerzmann, M., Sondergaard, L., Zeppenfeld, K., Ernst, S., Ladouceur, M., … Coats, L. (2020). ESC Scientific Document Group, 2020 ESC Guidelines for the management of adult congenital heart disease: The Task Force for the management of adult congenital heart disease of the European Society of Cardiology (ESC). European Heart Journal, 42(6), 563-645. https://doi.org/10.1093/eurheartj/ehaa554
Blue, G. M., Kasparian, N. A., Sholler, G. F., Kirk, E. P., & Winlaw, D. S. (2015). Genetic counselling in parents of children with congenital heart disease significantly improves knowledge about causation and enhances psychosocial functioning. International Journal of Cardiology, 178, 124-130. https://doi.org/10.1016/j.ijcard.2014.10.119
Blue, G. M., Kirk, E. P., Giannoulatou, E., Dunwoodie, S. L., Ho, J. W. K., Hilton, D. C. K., White, S. M., Sholler, G. F., Harvey, R. P., & Winlaw, D. S. (2014). Targeted next-generation sequencing identifies pathogenic variants in familial congenital heart disease. Journal of the American College of Cardiology, 64(23), 2498-2506. https://doi.org/10.1016/j.jacc.2014.09.048
Blue, G. M., Kirk, E. P., Giannoulatou, E., Sholler, G. F., Dunwoodie, S. L., Harvey, R. P., & Winlaw, D. S. (2017). Advances in the genetics of congenital heart disease, a clinician’s guide. Journal of the American College of Cardiology, 69(7), 859-870. https://doi.org/10.1016/j.jacc.2016.11.060
Botto, L. D., Lin, A. E., Riehle-Colarusso, T., Malik, S., & Correa, A. (2007). Seeking causes: Classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Research Part A: Clinical and Molecular Teratology, 79(10), 714-727. https://doi.org/10.1002/bdra.20403
Breckpot, J., Thienpont, B., Peeters, H., de Ravel, T., Singer, A., Rayyan, M., Allegaert, K., Vanhole, C., Eyskens, B., Vermeesch, J. R., Gewillig, M., & Devriendt, K. (2010). Array comparative genomic hybridization as a diagnostic tool for syndromic heart defects. The Journal of Pediatrics, 156(5), 810-817.e4. https://doi.org/10.1016/j.jpeds.2009.11.049
Brosig, C. L., Whitstone, B. N., Frommelt, M. A., Frisbee, S. J., & Leuthner, S. R. (2007). Psychological distress in parents of children with severe congenital heart disease: The impact of prenatal versus postnatal diagnosis. Journal of Perinatology, 27(11), 687-692. https://doi.org/10.1038/sj.jp.7211807
Brunetti-Pierri, N., Berg, J. S., Scaglia, F., Belmont, J., Bacino, C. A., Sahoo, T., Lalani, S. R., Graham, B., Lee, B., Shinawi, M., Shen, J., Kang, S.-H., Pursley, A., Lotze, T., Kennedy, G., Lansky-Shafer, S., Weaver, C., Roeder, E. R., Grebe, T. A., … Patel, A. (2008). Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nature Genetics, 40(12), 1466-1471. https://doi.org/10.1038/ng.279
Buckley, J. R., Kavarana, M. N., Chowdhury, S. M., & Scheurer, M. A. (2015). Current practice and utility of chromosome microarray analysis in infants undergoing cardiac surgery. Congenital Heart Disease, 10(3), E131-138. https://doi.org/10.1111/chd.12241
Carey, A. S., Liang, L. I., Edwards, J., Brandt, T., Mei, H., Sharp, A. J., Hsu, D. T., Newburger, J. W., Ohye, R. G., Chung, W. K., Russell, M. W., Rosenfeld, J. A., Shaffer, L. G., Parides, M. K., Edelmann, L., & Gelb, B. D. (2013). Effect of copy number variants on outcomes for infants with single ventricle heart defects. Circulation Cardiovascular Genetics, 6(5), 444-451. https://doi.org/10.1161/CIRCGENETICS.113.000189
Committee on Genetics and the Society for Maternal-Fetal Medicine. (2016). Committee Opinion No.682: Microarrays and next-generation sequencing technology: The use of advanced genetic diagnostic tools in obstetrics and gynecology. Obstetrics and Gynecology, 128(6), e262-e268. https://doi.org/10.1097/AOG.0000000000001817
Committee Opinion No. 640. (2015). Cell-free DNA screening for fetal aneuploidy. Obstetrics and Gynecology, 126(3), e31-e37. https://doi.org/10.1097/AOG.0000000000001051
Connor, J. A., Hinton, R. B., Miller, E. M., Sund, K. L., Ruschman, J. G., & Ware, S. M. (2014). Genetic testing practices in infants with congenital heart disease: Genetic testing practices in infants. Congenital Heart Disease, 9(2), 158-167. https://doi.org/10.1111/chd.12112
Connor, J. A., Kline, N. E., Mott, S., Harris, S. K., & Jenkins, K. J. (2010). The meaning of cost for families of children with congenital heart disease. Journal of Pediatric Health Care, 24(5), 318-325. https://doi.org/10.1016/j.pedhc.2009.09.002
Cowan, J. R., & Ware, S. M. (2015). Genetics and genetic testing in congenital heart disease. Clinics in Perinatology, 42(2), 373-ix. https://doi.org/10.1016/j.clp.2015.02.009
De Backer, J., Bondue, A., Budts, W., Evangelista, A., Gallego, P., Jondeau, G., Loeys, B., Peña, M. L., Teixido-Tura, G., van de Laar, I., Verstraeten, A., & Roos Hesselink, J. (2019). Genetic counselling and testing in adults with congenital heart disease: A consensus document of the ESC Working Group of Grown-Up Congenital Heart Disease, the ESC Working Group on Aorta and Peripheral Vascular Disease and the European Society of Human Genetics. European Journal of Preventive Cardiology, 27(13), 1423-1435. https://doi.org/10.1177/2047487319854552
Demir, F., Karadeniz, C., Atalay, S., Tekin, M., & Tutar, E. (2013). Screening of families of patients with left-sided cardiovascular anomalies. Pediatrics International, Official Journal of the Japan Pediatric Society, 55(5), 555-560. https://doi.org/10.1111/ped.12132
Donofrio, M. T., Moon-Grady, A. J., Hornberger, L. K., Copel, J. A., Sklansky, M. S., Abuhamad, A., Cuneo, B. F., Huhta, J. C., Jonas, R. A., Krishnan, A., Lacey, S., Lee, W., Michelfelder, E. C., Rempel, G. R., Silverman, N. H., Spray, T. L., Strasburger, J. F., Tworetzky, W., & Rychik, J. (2014). Diagnosis and treatment of fetal cardiac disease: A scientific statement from the american heart association. Circulation, 129(21), 2183-2242. https://doi.org/10.1161/01.cir.0000437597.44550.5d
Ehrich, M., Tynan, J., Mazloom, A., Almasri, E., McCullough, R., Boomer, T., Grosu, D., & Chibuk, J. (2017). Genome-wide cfDNA screening: Clinical laboratory experience with the first 10,000 cases. Genetics in Medicine, 19(12), 1332-1337. https://doi.org/10.1038/gim.2017.56
Ellison, J. W., Ravnan, J. B., Rosenfeld, J. A., Morton, S. A., Neill, N. J., Williams, M. S., Lewis, J., Torchia, B. S., Walker, C., Traylor, R. N., Moles, K., Miller, E., Lantz, J., Valentin, C., Minier, S. L., Leiser, K., Powell, B. R., Wilks, T. M., & Shaffer, L. G. (2012). Clinical utility of chromosomal microarray analysis. Pediatrics, 130(5), e1085-e1095. https://doi.org/10.1542/peds.2012-0568
Freeze, S. L., Landis, B. J., Ware, S. M., & Helm, B. M. (2016). Bicuspid aortic valve: A review with recommendations for genetic counseling. Journal of Genetic Counseling, 25(6), 1171-1178. https://doi.org/10.1007/s10897-016-0002-6
Geddes, G. C., Basel, D., Frommelt, P., Kinney, A., & Earing, M. (2017). Genetic testing protocol reduces costs and increases rate of genetic diagnosis in infants with congenital heart disease. Pediatric Cardiology, 38, 1465-1470. https://doi.org/10.1007/s00246-017-1685-7
Geddes, G. C., Sai-Suma Sumudrala, B. S., & Earing, M. G. (2020). Neonatal assessment of infants with heterotaxy. Clinics in Perinatology, 47(1), 171-182. https://doi.org/10.1016/j.clp.2019.10.011
Geddes, G. C., Syverson, E., & Earing, M. G. (2019). Three year experience of a clinical cardiovascular genetics program for infants with congenital heart disease. Congenital Heart Disease, 14(5), 832-837. https://doi.org/10.1111/chd.12817
Geng, J., Picker, J., Zheng, Z., Zhang, X., Wang, J., Hisama, F., Brown, D. W., Mullen, M. P., Harris, D., Stoler, J., Seman, A., Miller, D. T., Fu, Q., Roberts, A. E., & Shen, Y. (2014). Chromosome microarray testing for patients with congenital heart defects reveals novel disease causing loci and high diagnostic yield. BMC Genomics, 15(1), 1127. https://doi.org/10.1186/1471-2164-15-1127
Goldenberg, P. C., Adler, B. J., Parrott, A., Anixt, J., Mason, K., Phillips, J., Cooper, D. S., Ware, S. M., & Marino, B. S. (2017). High burden of genetic conditions diagnosed in a cardiac neurodevelopmental clinic. Cardiology in the Young, 27(3), 459-466. https://doi.org/10.1017/S104795111600072X
Gregg, A. R., Skotko, B. G., Benkendorf, J. L., Monaghan, K. G., Bajaj, K., Best, R. G., Klugman, S., & Watson, M. S. (2016). Noninvasive prenatal screening for fetal aneuploidy, 2016 update: A position statement of the American College of Medical Genetics and Genomics. Genetics in Medicine, 18(10), 1056-1065. https://doi.org/10.1038/gim.2016.97
Grønning Dale, M. T., Solberg, Ø., Holmstrøm, H., Landolt, M. A., Eskedal, L. T., & Vollrath, M. E. (2013). Well-being in mothers of children with congenital heart defects: A 3-year follow-up. Quality of Life Research, 22(8), 2063-2072. https://doi.org/10.1007/s11136-012-0326-0
Hales, A. R., & Mahle, W. T. (2014). Echocardiography screening of siblings of children with bicuspid aortic valve. Pediatrics, 133(5), e1212, e1217. https://doi.org/10.1542/peds.2013-3051
Harper, P. S. (2010). Practical genetic counselling (7th ed., p. 274). Edward Arnold (Publishers) Ltd. Chapter 19.
Hayeems, R. Z., Hoang, N., Chenier, S., Stavropoulos, D. J., Pu, S., Weksberg, R., & Shuman, C. (2015). Capturing the clinical utility of genomic testing: Medical recommendations following pediatric microarray. European Journal of Human Genetics, 23(9), 1135-1141. https://doi.org/10.1038/ejhg.2014.260
Helle, E., & Priest, J. R. (2020). Maternal obesity and diabetes mellitus as risk factors for congenital heart disease in the offspring. Journal of the American Heart Association, 9(8), e011541. https://doi.org/10.1161/JAHA.119.011541
Henderson, L. B., Applegate, C. D., Wohler, E., Sheridan, M. B., Hoover-Fong, J., & Batista, D. A. (2014). The impact of chromosomal microarray on clinical management: A retrospective analysis. Genetics in Medicine, 16(9), 657-664. https://doi.org/10.1038/gim.2014.18
Hinton, R. B. Jr, Martin, L. J., Tabangin, M. E., Mazwi, M. L., Cripe, L. H., & Benson, D. W. (2007). Hypoplastic left heart syndrome is heritable. Journal of the American College of Cardiology, 50(16), 1590-1595. https://doi.org/10.1016/j.jacc.2007.07.021
Hiratzka, L. F., Bakris, G. L., Beckman, J. A., Bersin, R. M., Carr, V. F., Casey, D. E., Eagle, K. A., Hermann, L. K., Isselbacher, E. M., Kazerooni, E. A., Kouchoukos, N. T., Lytle, B. W., Milewicz, D. M., Reich, D. L., Sen, S., Shinn, J. A., Svensson, L. G., & Williams, D. M. (2010). 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation, 121(13), (2010), e266-369. https://doi.org/10.1161/CIR.0b013e3181d4739e
Homsy, J., Zaidi, S., Shen, Y., Ware, J. S., Samocha, K. E., Karczewski, K. J., DePalma, S. R., McKean, D., Wakimoto, H., Gorham, J., Jin, S. C., Deanfield, J., Giardini, A., Porter, G. A., Kim, R., Bilguvar, K., Lopez-Giraldez, F., Tikhonova, I., Mane, S., … Chung, W. K. (2015). De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies. Science, 350(6265), 1262-1266. https://doi.org/10.1126/science.aac9396
Ito, S., Chapman, K. A., Kisling, M., & John, A. S. (2020). Genetic considerations for adults with congenital heart disease. Am J Med Genet Part C, 184C, 149-153. https://doi.org/10.1002/ajmg.c.31777
Jansen, F. A., Blumenfeld, Y. J., Fisher, A., Cobben, J. M., Odibo, A. O., Borrell, A., & Haak, M. C. (2015). Array comparative genomic hybridization and fetal congenital heart defects: A systematic review and meta-analysis. Ultrasound in Obstetrics and Gynecology, 45(1), 27-35. https://doi.org/10.1002/uog.14695
Jenkins, K. J., Correa, A., Feinstein, J. A., Botto, L., Britt, A. E., Daniels, S. R., Elixson, M., Webb, C. L. (2007). Noninherited risk factors and congenital cardiovascular defects: Current knowledge. Circulation, 115(23), 2995-3014. https://doi.org/10.1161/CIRCULATIONAHA.106.183216
Jerves, T., Beaton, A., & Kruszka, P. (2020). The genetic workup for structural congenital heart disease. American Journal of Medical Genetics Part C, 184(1), 178-186. https://doi.org/10.1002/ajmg.c.31759
Jia, Y., Louw, J. J., Breckpot, J., Callewaert, B., Barrea, C., Sznajer, Y., Gewillig, M., Souche, E., Dehaspe, L., Vermeesch, J. R., Lambrechts, D., Devriendt, K., & Corveleyn, A. (2015). The diagnostic value of next generation sequencing in familial nonsyndromic congenital heart defects. American Journal of Medical Genetics Part A, 167(8), 1822-1829. https://doi.org/10.1002/ajmg.a.37108
Jin, S. C., Homsy, J., Zaidi, S., Lu, Q., Morton, S., DePalma, S. R., Zeng, X., Qi, H., Chang, W., Sierant, M. C., Hung, W.-C., Haider, S., Zhang, J., Knight, J., Bjornson, R. D., Castaldi, C., Tikhonoa, I. R., Bilguvar, K., Mane, S. M., … Brueckner, M. (2017). Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands. Nature Genetics, 49(11), 1593-1601. https://doi.org/10.1038/ng.3970
Kalisch-Smith, J. I., Ved, N., & Sparrow, D. B. (2020). Environmental risk factors for congenital heart disease. Cold Spring Harbor Perspectives in Biology, 12(3), a037234. https://doi.org/10.1101/cshperspect.a037234
Kasparian, N. A., De Abreu Lourenco, R., Winlaw, D. S., Sholler, G. F., Viney, R., & Kirk, E. (2018). Tell me once, tell me soon: Parents' preferences for clinical genetics services for congenital heart disease. Genetics in Medicine, 20(11), 1387-1395. https://doi.org/10.1038/gim.2018.16
Kasparian, N. A., Fidock, B., Sholler, G. F., Camphausen, C., Murphy, D. N., Cooper, S. G., Kaul, R., Jones, O., Winlaw, D. S., & Kirk, E. P. (2014). Parents' perceptions of genetics services for congenital heart disease: The role of demographic, clinical, and psychological factors in determining service attendance. Genetics in Medicine, 16(6), 460-468. https://doi.org/10.1038/gim.2013.169
Kelle, A. M., Qureshi, M. Y., Olson, T. M., Eidem, B. W., & O'Leary, P. W. (2015). Familial incidence of cardiovascular malformations in hypoplastic left heart syndrome. The American Journal of Cardiology, 116(11), 1762-1766. https://doi.org/10.1016/j.amjcard.2015.08.045
Kerstjens-Frederikse, W. S., Du Marchie Sarvaas, G. J., Ruiter, J. S., Van Den Akker, P. C., Temmerman, A. M., Van Melle, J. P., Hofstra, R. M., & Berger, R. M. (2011). Left ventricular outflow tract obstruction: Should cardiac screening be offered to first-degree relatives? Heart (British Cardiac Society), 97(15), 1228-1232. https://doi.org/10.1136/hrt.2010.211433
Kerstjens-Frederikse, W. S., van de Laar, I. M. B. H., Vos, Y. J., Verhagen, J. M. A., Berger, R. M. F., Lichtenbelt, K. D., Klein Wassink-Ruiter, J. S., van der Zwaag, P. A., du Marchie Sarvaas, G. J., Bergman, K. A., Bilardo, C. M., Roos-Hesselink, J. W., Janssen, J. H. P., Frohn-Mulder, I. M., van Spaendonck-Zwarts, K. Y., van Melle, J. P., Hofstra, R. M. W., & Wessels, M. W. (2016). Cardiovascular malformations caused by NOTCH1 mutations do not keep left: Data on 428 probands with left-sided CHD and their families. Genetics in Medicine, 18(9), 914-923. https://doi.org/10.1038/gim.2015.193
Kim, D. S., Kim, J. H., Burt, A. A., Crosslin, D. R., Burnham, N., Kim, C. E., McDonald-McGinn, D. M., Zackai, E. H., Nicolson, S. C., Spray, T. L., Stanaway, I. B., Nickerson, D. A., Heagerty, P. J., Hakonarson, H., Gaynor, J. W., & Jarvik, G. P. (2016). Burden of potentially pathologic copy number variants is higher in children with isolated congenital heart disease and significantly impairs covariate-adjusted transplant-free survival. The Journal of Thoracic and Cardiovascular Surgery, 151(4), 1147-51.e4. https://doi.org/10.1016/j.jtcvs.2015.09.136
Kučienė, R., & Dulskienė, V. (2008). Selected environmental risk factors and congenital heart defects. Medicina, 44(11), 827. https://doi.org/10.3390/medicina44110104
Latham, G. J., Ross, F. J., Eisses, M. J., Richards, M. J., Geiduschek, J. M., & Joffe, D. C. (2016). Perioperative morbidity in children with elastin arteriopathy. Paediatric Anaesthesia, 26(9), 926-935. https://doi.org/10.1111/pan.12967
Lawoko, S., & Soares, J. J. (2002). Distress and hopelessness among parents of children with congenital heart disease, parents of children with other diseases, and parents of healthy children. Journal of Psychosomatic Research, 52(4), 193-208. https://doi.org/10.1016/s0022-3999(02)00301-x
Lawoko, S., & Soares, J. J. (2006). Psychosocial morbidity among parents of children with congenital heart disease: A prospective longitudinal study. Heart and Lung, 35(5), 301-314. https://doi.org/10.1016/j.hrtlng.2006.01.004
Lee, W., Anton, T., Copel, J., DeVore, G., & Kaimal, A. (2020). AIUM practice parameter for the performance of fetal echocardiography. Journal of Ultrasound in Medicine, 39, E5-E16.
Liu, X., Chen, W., Li, W., Priest, J. R., Fu, Y., Pang, K.-J., Ma, B., Han, B., Liu, X., Hu, S., & Zhou, Z. (2020). Exome-based case-control analysis highlights the pathogenic role of ciliary genes in transposition of the great arteries. Circulation Research, 126(7), 811-821. https://doi.org/10.1161/CIRCRESAHA.119.315821
Loffredo, C. A., Chokkalingam, A., Sill, A. M., Boughman, J. A., Clark, E. B., Scheel, J., & Brenner, J. I. (2004). Prevalence of congenital cardiovascular malformations among relatives of infants with hypoplastic left heart, coarctation of the aorta, and d-transposition of the great arteries. American Journal of Medical Genetics Part A, 124A(3), 225-230. https://doi.org/10.1002/ajmg.a.20366
Lord, J., McMullan, D. J., Eberhardt, R. Y., Rinck, G., Hamilton, S. J., Quinlan-Jones, E., Prigmore, E., Keelagher, R., Best, S. K., Carey, G. K., Mellis, R., Robart, S., Berry, I. R., Chandler, K. E., Cilliers, D., Cresswell, L., Edwards, S. L., Gardiner, C., Henderson, A., … Prenatal Assessment of Genomes and Exomes Consortium. (2019). Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): A cohort study. Lancet (London, England), 393(10173), 747-757. https://doi.org/10.1016/S0140-6736(18)31940-8
Lynch, T. A., & Abel, D. E. (2015). Teratogens and congenital heart sisease. Journal of Diagnostic Medical Sonography, 31(5), 301-305. https://doi.org/10.1177/8756479315598524
Mahler, G. J., & Butcher, J. T. (2011). Cardiac developmental toxicity. Birth Defects Research Part C, 93(4), 291-297. https://doi.org/10.1002/bdrc.20219
Manning, M., & Hudgins, L. (2010). Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genetics in Medicine, 12(11), 742-745. https://doi.org/10.1097/GIM.0b013e3181f8baad
Marian, A. J., Brugada, R., Roberts, R. (2011). Cardiovascular diseases caused by genetic abnormalities. In V. Fuster, R. A. Walsh, & R. A. Harrington (Eds.), Hurst’s the heart (13th ed.). McGraw-Hill. chap 82.
Mazor Dray, E., & Marelli, A. J. (2015). Adult congenital heart disease: Scope of the problem. Cardiology Clinics, 33(4), 503-512. https://doi.org/10.1016/j.ccl.2015.07.001
McBride, K. L., Pignatelli, R., Lewin, M., Ho, T., Fernbach, S., Menesses, A., Lam, W., Leal, S. M., Kaplan, N., Schliekelman, P., Towbin, J. A., & Belmont, J. W. (2005). Inheritance analysis of congenital left ventricular outflow tract obstruction malformations: Segregation, multiplex relative risk, and heritability. American Journal of Medical Genetics Part A, 134A(2), 180-186. https://doi.org/10.1002/ajmg.a.30602
Miller, D. T., Adam, M. P., Aradhya, S., Biesecker, L. G., Brothman, A. R., Carter, N. P., Church, D. M., Crolla, J. A., Eichler, E. E., Epstein, C. J., Faucett, W. A., Feuk, L., Friedman, J. M., Hamosh, A., Jackson, L., Kaminsky, E. B., Kok, K., Krantz, I. D., Kuhn, R. M., … Ledbetter, D. H. (2010). Consensus statement: Chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. The American Journal of Human Genetics, 86(5), 749-764. https://doi.org/10.1016/j.ajhg.2010.04.006
Nees, S. N., & Chung, W. K. (2020). Genetic basis of human congenital heart disease. Cold Spring Harbor Perspectives in Biology, 12(9), a036749. https://doi.org/10.1101/cshperspect.a036749
Nielsen, G. L., Møller, M., & Sørensen, H. T. (2006). HbA1c in early diabetic pregnancy and pregnancy outcomes: A Danish population-based cohort study of 573 pregnancies in women with type 1 diabetes. Diabetes Care, 29(12), 2612-2616. https://doi.org/10.2337/dc06-0914
Nugent, D. J., Romano, A. A., Sabharwal, S., & Cooper, D. L. (2018). Evaluation of bleeding disorders in patients with Noonan syndrome: A systematic review. Journal of Blood Medicine, 9, 185-192. https://doi.org/10.2147/JBM.S164474
Øyen, N., Poulsen, G., Boyd, H. A., Wohlfahrt, J., Jensen, P. K., & Melbye, M. (2009). Recurrence of congenital heart defects in families. Circulation, 120(4), 295-301. https://doi.org/10.1161/CIRCULATIONAHA.109.857987
Paige, S. L., Saha, P., & Priest, J. R. (2018). Beyond gene panels: Whole exome sequencing for diagnosis of congenital heart disease. Circulation Genomic and Precision Medicine, 11(3), e002097. https://doi.org/10.1161/CIRCGEN.118.002097
Pasipoularides, A. (2018). The new era of whole-exome sequencing in congenital heart disease: Brand-new insights into rare pathogenic variants. Journal of Thoracic Disease, 10(Suppl 17), S1923. https://doi.org/10.21037/jtd.2018.05.56
Patel, S. S., & Burns, T. L. (2013). Nongenetic risk factors and congenital heart defects. Pediatric Cardiology, 34(7), 1535-1555. https://doi.org/10.1007/s00246-013-0775-4
Petracchi, F., Sisterna, S., Igarzabal, L., & Wilkins-Haug, L. (2019). Fetal cardiac abnormalities: Genetic etiologies to be considered. Prenatal Diagnosis, 39(9), 758-780. https://doi.org/10.1002/pd.5480
Petrovski, S., Aggarwal, V., Giordano, J. L., Stosic, M., Wou, K., Bier, L., Spiegel, E., Brennan, K., Stong, N., Jobanputra, V., Ren, Z., Zhu, X., Mebane, C., Nahum, O., Wang, Q., Kamalakaran, S., Malone, C., Anyane-Yeboa, K., Miller, R., … Wapner, R. J. (2019). Whole-exome sequencing in the evaluation of fetal structural anomalies: A prospective cohort study. Lancet (London, England), 393(10173), 758-767. https://doi.org/10.1016/S0140-6736(18)32042-7
Pierpont, M. E., Brueckner, M., Chung, W. K., Garg, V., Lacro, R. V., McGuire, A. L., Mital, S., Priest, J. R., Pu, W. T., Roberts, A., Ware, S. M., Gelb, B. D., Russell, M. W., & American Heart Association Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Genomic and Precision Medicine. (2018). Genetic basis for congenital heart disease: Revisited: A scientific statement from the american heart association. Circulation, 138(21), e653-e711. https://doi.org/10.1161/CIR.0000000000000606
Posch, M. G., Boldt, L.-H., Polotzki, M., Richter, S., Rolf, S., Perrot, A., Dietz, R., Özcelik, C., & Haverkamp, W. (2010). Mutations in the cardiac transcription factor GATA4 in patients with lone atrial fibrillation. European Journal of Medical Genetics, 53(4), 201-203. https://doi.org/10.1016/j.ejmg.2010.03.008
Postma, A. V., van Engelen, K., van de Meerakker, J., Rahman, T., Probst, S., Baars, M. J., Bauer, U., & Klaassen, S. (2011). Mutations in the sarcomere gene MYH7 in Ebstein anomaly. Circulation Cardiovascular Genetics, 4(1), 43-50. https://doi.org/10.1161/CIRCGENETICS.110.957985
Preuss, C., Capredon, M., Wünnemann, F., Chetaille, P., Prince, A., Godard, B., Leclerc, S., Sobreira, N., Ling, H., Awadalla, P., Thibeault, M., Khairy, P., Samuels, M. E., & Andelfinger, G. (2016). Family based whole exome sequencing reveals the multifaceted role of notch signaling in congenital heart disease. PLoS Genetics, 12(10), e1006335. https://doi.org/10.1371/journal.pgen.1006335
Qiao, F., Wang, Y., Zhang, C., Zhou, R., Wu, Y., Wang, C., Meng, L., Mao, P., Cheng, Q., Luo, C., Hu, P., & Xu, Z. (2020). Comprehensive evaluation of genetic variants in fetuses with congenital heart defect using chromosomal microarray analysis and exome sequencing. Ultrasound in Obstetrics and Gynecology : The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology, https://doi.org/10.1002/uog.23532. Advance online publication
Reuter, M. S., Chaturvedi, R. R., Liston, E., Manshaei, R., Aul, R. B., Bowdin, S., Cohn, I., Curtis, M., Dhir, P., Hayeems, R. Z., Hosseini, S. M., Khan, R., Ly, L. G., Marshall, C. R., Mertens, L., Okello, J. B. A., Pereira, S. L., Raajkumar, A., Seed, M., … Jobling, R. K. (2020). The cardiac genome clinic: Implementing genome sequencing in pediatric heart disease. Genetics in Medicine, 22(6), 1015-1024. https://doi.org/10.1038/s41436-020-0757-x
Reuter, M. S., Jobling, R., Chaturvedi, R. R., Manshaei, R., Costain, G., Heung, T., Curtis, M., Hosseini, S. M., Liston, E., Lowther, C., Oechslin, E., Sticht, H., Thiruvahindrapuram, B., Mil, S. V., Wald, R. M., Walker, S., Marshall, C. R., Silversides, C. K., Scherer, S. W., … Bassett, A. S. (2019). Haploinsufficiency of vascular endothelial growth factor related signaling genes is associated with tetralogy of Fallot. Genetics in Medicine, 21(4), 1001-1007. https://doi.org/10.1038/s41436-018-0260-9
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., Voelkerding, K., & Rehm, H. L. (2015). Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine, 17(5), 405-424. https://doi.org/10.1038/gim.2015.30
Shi, X., Cheng, L., Jiao, X., Chen, B., Li, Z., Liang, Y., Liu, W., Wang, J., Liu, G., Xu, Y., Sun, J., Fu, Q., Lu, Y., & Chen, S. (2018). Rare copy number variants identify novel genes in sporadic total anomalous pulmonary vein connection. Frontiers in Genetics, 9, 559. https://doi.org/10.3389/fgene.2018.00559
Shikany, A. R., Parrott, A., James, J., Madueme, P., Nicole Weaver, K., Cassidy, C., Khoury, P. R., & Miller, E. M. (2019). Left ventricular outflow tract obstruction: Uptake of familial cardiac screening and parental knowledge from a single tertiary care center. Journal of Genetic Counseling, 28(4), 779-789. https://doi.org/10.1002/jgc4.1117
Sifrim, A., Hitz, M.-P., Wilsdon, A., Breckpot, J., Turki, S. H. A., Thienpont, B., McRae, J., Fitzgerald, T. W., Singh, T., Swaminathan, G. J., Prigmore, E., Rajan, D., Abdul-Khaliq, H., Banka, S., Bauer, U. M. M., Bentham, J., Berger, F., Bhattacharya, S., Bu'Lock, F., … Hurles, M. E. (2016). Distinct genetic architectures for syndromic and nonsyndromic congenital heart defects identified by exome sequencing. Nature Genetics, 48(9), 1060-1065. https://doi.org/10.1038/ng.3627
Stout, K. K., Daniels, C. J., Aboulhosn, J. A., Bozkurt, B., Broberg, C. S., Colman, J. M., Crumb, S. R., Dearani, J. A., & Van Hare, G. F. (2019). 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology, 73(12), 1494-1563. https://doi.org/10.1016/j.jacc.2018.08.1028
Sun, H., Yi, T., Hao, X., Yan, H., Wang, J., Li, Q., Gu, X., Zhou, X., Wang, S., Wang, X., Wan, P., Han, L., Chen, J., Zhu, H., Zhang, H., & He, Y. (2019). The contribution of single-gene defects to congenital cardiac left-sided lesions in the prenatal setting. Ultrasound in Obstetrics and Gynecology, 56(2), 225-232. https://doi.org/10.1002/uog.21883
Szot, J. O., Cuny, H., Blue, G. M., Humphreys, D. T., Ip, E., Harrison, K., Sholler, G. F., Giannoulatou, E., Leo, P., Duncan, E. L., Sparrow, D. B., Ho, J. W. K., Graham, R. M., Pachter, N., Chapman, G., Winlaw, D. S., & Dunwoodie, S. L. (2018). A screening approach to identify clinically actionable variants causing congenital heart disease in exome data. Circulation: Genomic and Precision Medicine, 11(3), e001978. https://doi.org/10.1161/CIRCGEN.117.001978
Turan, S., Asoglu, M. R., Gabbay-Benzly, R., Doyle, L., Harman, C., & Turan, O. M. (2018). Yield of chromosomal microarray analysis in fetuses with congenital heart defects. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 221, 172-176. https://doi.org/10.1016/j.ejogrb.2017.12.019
Van der Linde, I., Hiemstra, Y. L., Bökenkamp, R., van Mil, A. M., Breuning, M. H., Ruivenkamp, C., Ten Broeke, S. W., & Barge-Schaapveld, D. (2017). A Dutch MYH7 founder mutation, p. (Asn1918Lys), is associated with early onset cardiomyopathy and congenital heart defects. Netherlands Heart Journal, 25(12), 675-681. https://doi.org/10.1007/s12471-017-1037-5
Van Engelen, K., Baars, M. J., Felix, J. P., Postma, A. V., Mulder, B. J., & Smets, E. M. (2013). The value of the clinical geneticist caring for adults with congenital heart disease: Diagnostic yield and patients' perspective. American Journal of Medical Genetics Part A, 161A(7), 1628-1637. https://doi.org/10.1002/ajmg.a.35973
Van Engelen, K., Baars, M. J., van Rongen, L. T., van der Velde, E. T., Mulder, B. J., & Smets, E. M. (2011). Adults with congenital heart disease: Patients' knowledge and concerns about inheritance. American Journal of Medical Genetics Part A, 155A(7), 1661-1667. https://doi.org/10.1002/ajmg.a.34068
Waldron, L., Steimle, J. D., Greco, T. M., Gomez, N. C., Dorr, K. M., Kweon, J., Temple, B., Yang, X. H., Wilczewski, C. M., Davis, I. J., Cristea, I. M., Moskowitz, I. P., & Conlon, F. L. (2016). The cardiac TBX5 interactome reveals a chromatin remodeling network essential for cardiac septation. Developmental Cell, 36(3), 262-275. https://doi.org/10.1016/j.devcel.2016.01.009
Wang, Y., Cao, L. I., Liang, D., Meng, L., Wu, Y., Qiao, F., Ji, X., Luo, C., Zhang, J., Xu, T., Yu, B., Wang, L., Wang, T., Pan, Q., Ma, D., Hu, P., & Xu, Z. (2018). Prenatal chromosomal microarray analysis in fetuses with congenital heart disease: A prospective cohort study. American Journal of Obstetrics and Gynecology, 218(2), 244.e1-244.e17. https://doi.org/10.1016/j.ajog.2017.10.225
Wender-Ozegowska, E., Wróblewska, K., Zawiejska, A., Pietryga, M., Szczapa, J., & Biczysko, R. (2005). Threshold values of maternal blood glucose in early diabetic pregnancy-prediction of fetal malformations. Acta Obstetricia Et Gynecologica Scandinavica, 84(1), 17-25. https://doi.org/10.1111/j.0001-6349.2005.00606.x
Westphal, D. S., Leszinski, G. S., Rieger-Fackeldey, E., Graf, E., Weirich, G., Meitinger, T., Ostermayer, E., Oberhoffer, R., & Wagner, M. (2019). Lessons from exome sequencing in prenatally diagnosed heart defects: A basis for prenatal testing. Clinical Genetics, 95(5), 582-589. https://doi.org/10.1111/cge.13536
Williams, K., Carson, J., & Lo, C. (2019). Genetics of congenital heart disease. Biomolecules, 9(12), 879. https://doi.org/10.3390/biom9120879
Yang, Y.-Q., Wang, M.-Y., Zhang, X.-L., Tan, H.-W., Shi, H.-F., Jiang, W.-F., Wang, X.-H., Fang, W.-Y., & Liu, X. U. (2011). GATA4 loss-of-function mutations in familial atrial fibrillation. Clinica Chimica Acta; International Journal of Clinical Chemistry, 412(19-20), 1825-1830. https://doi.org/10.1016/j.cca.2011.06.017
Zaidi, S., & Brueckner, M. (2017). Genetics and genomics of congenital heart disease. Circulation Research, 120(6), 923-940. https://doi.org/10.1161/CIRCRESAHA.116.309140
Zaidi, S., Choi, M., Wakimoto, H., Ma, L., Jiang, J., Overton, J. D., Romano-Adesman, A., Bjornson, R. D., Breitbart, R. E., Brown, K. K., Carriero, N. J., Cheung, Y. H., Deanfield, J., DePalma, S., Fakhro, K. A., Glessner, J., Hakonarson, H., Italia, M. J., Kaltman, J. R., … Lifton, R. P. (2013). De novo mutations in histone-modifying genes in congenital heart disease. Nature, 498(7453), 220-223. https://doi.org/10.1038/nature12141
Zhou, W., Zhao, L., Jiang, J. Q., Jiang, W. F., Yang, Y. Q., & Qiu, X. B. (2015). A novel TBX5 loss-of-function mutation associated with sporadic dilated cardiomyopathy. International Journal of Molecular Medicine, 36(1), 282-288. https://doi.org/10.3892/ijmm.2015.2206

Auteurs

Hannah E Ison (HE)

Stanford Center for Inherited Cardiovascular Disease, Stanford Health Care, Stanford, California, USA.

Emily L Griffin (EL)

Department of Pediatrics, Columbia University Medical Center, New York, New York, USA.

Ashley Parrott (A)

Genome Medical, Inc., San Francisco, California, USA.

Amy R Shikany (AR)

Cincinnati Children's Hospital Medical Center, The Heart Institute, Cincinnati, Ohio, USA.

Lindsay Meyers (L)

Genome Medical, Inc., San Francisco, California, USA.

Matthew J Thomas (MJ)

Department of Pediatrics, Division of Genetics, University of Virginia School of Medicine, Charlottesville, Virginia, USA.

Erin Syverson (E)

Department of Pediatrics, Division of Genetics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

Erin M Demo (EM)

Sibley Heart Center Cardiology at Children's Healthcare of Atlanta, Atlanta, Georgia, USA.

Kristi K Fitzgerald (KK)

Nemours Cardiac Center, Alfred I. DuPont Hospital for Children, Wilmington, Delaware, USA.

Sara Fitzgerald-Butt (S)

Department of Medical & Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Katie L Ziegler (KL)

Myriad Women's Health, Inc, San Francisco, California, USA.

Allison F Schartman (AF)

Department of Obstetrics & Gynecology, Division of Maternal Fetal Medicine, Indiana University Health, Indianapolis, Indiana, USA.

Kristyne M Stone (KM)

Department of Obstetrics & Gynecology, Division of Maternal Fetal Medicine, Indiana University Health, Indianapolis, Indiana, USA.

Benjamin M Helm (BM)

Department of Medical & Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Department of Epidemiology, Indiana University Fairbanks School of Public Health, Indianapolis, Indiana, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH